Back to Agenda
New Medical Device Regulations in the EU
Session Chair(s)
John Wilkinson
Director of Devices
MHRA, United Kingdom
This session will focus on the new EU Medical Device Regulation. Updates on legislative process, expectations and content and implementation of the upcoming changes will be extensively discussed. After this session, you will be up to date on the latest developments around this very important regulation and its implications across the medtech sector. The session will include an interactive panel, in which the panelist will share their insights on any questions you might have.
Speaker(s)
Perspective of a Member State
Matthias Neumann
Federal Ministry of Health (BMG), Germany
Changing Role of Notified Bodies
Gert Bos, PhD, MSc
Qserve Group B.V., Netherlands
Chief Scientific Oficer, Executive Director, Partner
Impact on Industry
Peter Schroeer, RAC
Johnson & Johnson, Germany
Senior Director, Regulatory Policy Innovation
Panel Discussion
Reinhard Berger, DrSc, MSc
Consulting-Advising, Austria
Regulatory Affairs Medical Devices
Panel Discussion
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh
Tüv Süd, Netherlands
Global Director Regulatory Strategy
Have an account?